Skip to main content
. 2013 Mar 7;8(3):e58735. doi: 10.1371/journal.pone.0058735

Figure 1. Preliminary validation of four candidate proteins.

Figure 1

Four candidate proteins underwent preliminary validation were tested by ELISA in paired samples from 20 patients at active aGvHD onset and after complete response(CR). (A) Ceruloplasmin (CP) (Diagnosis Vs. CR p<0.001), (B) alpha-1-acid glycoprotein (AGP) (Diagnosis Vs. CR p = 0.031), (C) Complement factor H (CFH) (Diagnosis Vs. CR p  = 0.052), (D) Myeloperoxidase (MPO) (Diagnosis Vs. CR p = 0.073).